T-cell prolymphocytic leukemia medical therapy: Difference between revisions
Jump to navigation
Jump to search
Carlos Lopez (talk | contribs) No edit summary |
Carlos Lopez (talk | contribs) No edit summary |
||
Line 16: | Line 16: | ||
Other chemotherapy drugs, called purine analogues, are often used to treat PLL and seem to be effective: | Other chemotherapy drugs, called purine analogues, are often used to treat PLL and seem to be effective: | ||
* [[Fludarabine | * [[Fludarabine]] | ||
* Cladribine | * [[Cladribine]] | ||
* Pentostatin | * [[Pentostatin]] | ||
==References== | ==References== |
Revision as of 14:54, 30 September 2015
T-cell prolymphocytic leukemia Microchapters |
Differentiating T-cell Prolymphocytic Leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
T-cell prolymphocytic leukemia medical therapy On the Web |
American Roentgen Ray Society Images of T-cell prolymphocytic leukemia medical therapy |
Directions to Hospitals Treating T-cell prolymphocytic leukemia |
Risk calculators and risk factors for T-cell prolymphocytic leukemia medical therapy |
Overview
Medical Therapy
TPLL responds better when combinations of chemotherapy drugs are used. Some combinations that may be used are:
- CVP – cyclophosphamide (Cytoxan, Procytox), vincristine (Oncovin) and prednisone (Deltasone)
- CHOP – cyclophosphamide, doxorubicin (Adriamycin), vincristine and prednisone
Other chemotherapy drugs, called purine analogues, are often used to treat PLL and seem to be effective: